Odd Lot Index

UTAH MEDICAL PRODUCTS INC UTMD

Terms unclear

Unclear — read the filing yourself
StatusClosed
Closing date2002-11-08
How it is pricedFixed price
Odd-lot thresholdFewer than 100 shares
Must tender everything you holdNot stated
Must tick the odd-lot box on the formYes
Price offeredUSD $17.05 per share
Cleared at$17.05
Most an odd-lot tender could be$1,687.95

How it finished

Shares tendered750,000

Where each of these comes from

Every line above was read out of the filing. Here is the wording it was read from, so you can check it.

election_required = True...ESENTS ALL OF THE SHARES I OWN? Odd lots are not subject to proration. That means all properly tendered odd lots will be purchased in entirety without proration in the event that more shares are tendered than we purchase. To properly tender odd lots, you must complete the section entitled "Odd Lots" in the Letter of Transmittal. See Section 1. WILL I HAVE TO PAY BROKERAGE COMMISSIONS IF I TENDER MY SHARES? If you are a registered shareholder and you tender your shares directly to the depositary, you will not incur any brokerage commissions. If you hold your shares through a broker or a bank, we urge you to consult your broker or bank to determine whether they c...
expiry = 2002-11-08...PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 750,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $17.05 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON FRIDAY, NOVEMBER 8, 2002, UNLESS THE OFFER IS EXTENDED. ______________________________________________ Utah Medical Products, Inc., a Utah corporation ("UTMD" or the "Company"), hereby invites its stockholders to tender up to 750,000 shares of its Common Stock, pa...
listed = True...on, to purchase more than 750,000 Shares pursuant to the Offer. See Section 14. The Offer is not conditioned upon any minimum number of Shares being tendered. The Offer is, however, subject to certain other conditions. See Section 6. The Shares are listed and traded on The Nasdaq Stock Market ("Nasdaq") under the symbol "UTMD." On September 30, 2002, the last full Nasdaq trading day prior to announcement of the Offer, the closing per Share sales price as reported by Nasdaq was $16.07 per Share. Stockholders are urged to obtain current market quotations for the shares. See Section 7. The Board of Directors of the Company has approved t...
mechanism = FIXED...--------------------- Name: Kevin L. Cornwell Title: Chairman and Chief Executive Officer Dated: October 11, 2002 EXHIBIT (a)(1)(A) UTAH MEDICAL PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 750,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $17.05 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON FRIDAY, NOVEMBER 8, 2002, UNLESS THE OFFER IS EXTENDED. ______________________________________________ Utah Medical Products, Inc., a Utah corporation ("UTMD" or the "Company"), hereby invites its stockholders to tender up to 750,000 shares of i...
mechanism = FIXED...shareholder's tendered shares, even if the number of shares returned to the shareholder due to proration is less than 100 shares. Although the Company believes all the revisions to its "Offer to Purchase For Cash Up To 750,000 Shares of Its Common Stock At a Purchase Price of $17.05 Per Share" documentation are minor, it urges shareholders to access and read the information before deciding whether to tender or refrain from tendering their shares. This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell any shares of the Company's common stock. The solicitation to...
price = USD 17.05...e Officer Dated: October 11, 2002 EXHIBIT (a)(1)(A) UTAH MEDICAL PRODUCTS, INC. OFFER TO PURCHASE FOR CASH UP TO 750,000 SHARES OF ITS COMMON STOCK, PAR VALUE $.01 PER SHARE, AT A PURCHASE PRICE OF $17.05 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON FRIDAY, NOVEMBER 8, 2002, UNLESS THE OFFER IS EXTENDED. ______________________________________________ Utah Medical Products,...
price = USD 17.05...reholder due to proration is less than 100 shares. Although the Company believes all the revisions to its "Offer to Purchase For Cash Up To 750,000 Shares of Its Common Stock At a Purchase Price of $17.05 Per Share" documentation are minor, it urges shareholders to access and read the information before deciding whether to tender or refrain from tendering their shares. This press release is for informational purposes only and is n...
threshold = 100...applicable, on the Notice of Guaranteed Delivery. The Company also reserves the right, but will not be obligated, to purchase all Shares duly tendered by any stockholder who tendered all Shares owned beneficially and who, as a result of proration, would then own beneficially an aggregate of fewer than 100 Shares. If the Company exercises this right, it will increase the number of Shares that it is offering to purchase by the number of Shares purchased through the exercise of such right. 7 PRORATION. In the event that proration of tendered Shares is required, the Company will determine the proration factor as soon as practicable following the Exp...
txn_type = TENDER_OFFER...rights issued pursuant to the Rights Agreement, dated as of October 28, 1994, between Utah Medical Products, Inc. and Registrar and Transfer Company as Rights Agent, at a price of $17.05 per Share, upon the terms and subject to the conditions set forth in the Offer to Purchase dated October 11, 2002 (the "Offer to Purchase"), and in the related Letter of Transmittal which, as they may be amended from time to time, together constitute the "Offer," copies of which are attached as Exhibit (a)(1)(A) and (a)(1)(B), respectively. This Amendment No. 2 to the Schedule TO is intended to satisfy the reporting requiremen...
txn_type = TENDER_OFFER...rights issued pursuant to the Rights Agreement, dated as of October 28, 1994, between Utah Medical Products, Inc. and Registrar and Transfer Company as Rights Agent, at a price of $17.05 per Share, upon the terms and subject to the conditions set forth in the Offer to Purchase dated October 11, 2002 (the "Offer to Purchase"), and in the related Letter of Transmittal which, as they may be amended from time to time, together constitute the "Offer," copies of which were previously filed on Amendment No. 2 to the Schedule TO as Exhibit (a)(1)(A) and (a)(1)(B), respectively. This Amendment No. 3 to the Schedule TO...
final_price = 17.05...hares returned to the shareholder due to proration is less than 100 shares. Although the Company believes all the revisions to its "Offer to Purchase For Cash Up To 750,000 Shares of Its Common Stock At a Purchase Price of $17.05 Per Share" documentation are minor, it urges shareholders to access and read the information before deciding whether to tender or refrain from tendering their shares. This press release is for informational purposes only and is not an offer to buy or the solicitation of an offer to sell a...
tendered = 750000...nder offer: [ ] This Amendment No. 3 to the Tender Offer Statement on Schedule TO relates to the tender offer by Utah Medical Products, Inc., a Utah corporation ("UTMD" or the "Company"), to purchase 750,000 shares, or such lesser number of shares as are validly tendered and not withdrawn, of its Common Stock, par value $.01 per share, including the associated common stock purchase rights issued pursuant to the Rights Agreement, dated as of October 28, 1994, between Utah Medical Products, Inc. and Registrar and Transfer Company as Rights Agent,...

The filings

FiledFormRoleOn EDGAR
2002-10-11SC TO-Ioriginal (governing)View
2002-11-01SC TO-I/AamendmentView